Stock Price
0.49
Daily Change
0.03 5.43%
Monthly
42.65%
Yearly
340.91%
Q1 Forecast
0.49

Starpharma Holdings reported AUD-4.85M in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Medical Developments International AUD 1.78M 3.78M Dec/2024
Mesoblast USD -17.78M 17.03M Jun/2025
Neuren Pharmaceuticals AUD 176.7M 166.79M Dec/2024